Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the risk of death for patients with advanced squamous non-small cell lung cancer. The data, filed with the Hong Kong stock exchange on Monday and selected for the American Society […]<br /> This story continues at The Next Web [...]
Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Most enterprises can't stop stage-three AI agent threats, VentureBeat survey finds
A rogue AI agent at Meta passed every identity check and still exposed sensitive data to unauthorized employees in March. Two weeks later, Mercor, a $10 billion AI startup, confirmed a supply-chain br [...]
FDA approves at-home pap smear alternative device for cervical cancer screening
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]
Ambrosia Sky is an essay on death masquerading as a sci-fi cleaning sim
Dalia is a death cleaner.<br /> Death cleaning, as we know it, is the process of sanitizing and tidying the spaces where people take their final breaths, sometimes long after their bodies have b [...]
Private Internet Access VPN review: Both more and less than a budget VPN
I came into this review thinking of Private Internet Access (PIA) as one of the better VPNs. It's in the Kape Technologies portfolio, along with the top-tier ExpressVPN and the generally reliable [...]